Cellular Health Screening Market Size, Share & Trends Report

Cellular Health Screening Market Size, Share & Trends Analysis Report By Test Type (Single Test Panels, Multi-test Panels), By Sample Test (Blood, Saliva) By Collection Sites (Home, Hospitals), And Segment Forecasts, 2021 - 2028

  • Published Date: Jun, 2021
  • Base Year for Estimate: 2020
  • Report ID: GVR-3-68038-972-2
  • Format: Electronic (PDF)
  • Historical Data: 2016 - 2020
  • Number of Pages: 130

Report Overview

The global cellular health screening market size was valued at USD 2.22 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 6.3% from 2021 to 2028. Cellular health screening facilitates easy and rapid understanding of one’s health at a cellular level. This technology helps in identifying areas that need immediate support and enables professionals to develop an individualized plan to achieve effective results. Due to the COVID-19 pandemic, market players witnessed a decline in their sales and base testing volume. Moreover, the supply chain is disrupted due to governmental impositions and restrictions on transportation, export, and import of products, raw materials, etc. during the pandemic. This has led to a decrease in the demand; many of the organizations have diversified their product portfolios from cellular health testing line to COVID-19 molecular and antibody testing, which can equally offset the decrease in base testing volume.

U.S. cellular health screening market size, by test type, 2016 - 2028 (USD Million)

Applications of home-based diagnostic tests are significantly increasing globally. Public awareness campaigns aimed at identifying the symptoms of chronic diseases and ways to prevent them play an important role in controlling the spread of the disease. Thus, increased patient awareness has led to high demand for cellular health screening kits and services. The use of these devices also eliminates the need to wait for deciphering test results as well as aids in optimization of timely treatment decision, improves the efficacy of care provided, and significantly reduces diagnosis cost, especially in resource-constrained settings where laboratory infrastructure is weak.

Several research studies are indicative of the correlation between cancers and telomere length. Telomere shortening as a tumor suppressor proves to be a major factor in aggravated forms of cancer. Although it has been established that the length of telomeres is influenced by a variety of factors, such as infections, inflammation, and stress, these factors, particularly inflammation, resulting in oxidative stress, leading to telomere erosion.

Research supports telomere maintenance to being a major element for effects of environmental, lifestyle, and genetic issues on aging and related diseases. Therefore, the rate of telomere change facilitates a vital understanding of biological aging and genetic diseases. Furthermore, a decline of telomere length has been linked to age-related pathological issues, including Cardiovascular Diseases (CVDs), cancer, and reduced immune function. Thus, with the rising incidence of chronic diseases, the demand for cellular health screening is likely to increase in the coming years.

The rising number of programs by various organizations aimed at increasing awareness about preventive healthcare-based testing products and services will also augment market growth. Furthermore, collaborations, such as those undertaken by the CDC, National Cervical Cancer Coalition, the U.S. Preventive Services Task Force (USPSTF), WHO, and others, for cervical cancer screening are expected to boost the market growth during the forecast period. In addition, major market players are undertaking initiatives to increase awareness about cervical and vaginal cancer screening.

Test Type Insights

The single test panels segment dominated the market in 2020 with a revenue share of 80.18%. The single test panels segment is further segmented into telomere, oxidative stress, inflammation, and heavy metal tests. The telomere sub-segment held the highest share in this market. These panels provide accurate data and aid in performing efficient screening tests to measure the length of the telomere, thereby preventing diseases. Hence, increasing demand for preventive healthcare screening products and services is anticipated to boost the market growth.

The multi-test panels segment is projected to register the fastest CAGR during the forecast period. The market inclination toward multi-test panels is rising since they offer results for multiple biomarkers in a single exam. They have multiple advantages, such as advanced diagnostic precision, enhanced diagnostic competence, and reduced diagnostic cost.

Sample Test Insights

The blood sample segment held the dominant market share of 48.15% in 2020, as blood samples are most frequently used by clinicians to evaluate organ functions, diagnose diseases & conditions, analyze risk factors, determine medicinal efficacy, and assess blood clotting. In addition, the introduction of new blood-based cellular health screening tests has further supported the segment growth. For instance, in 2018, LabCorp Holdings introduced a blood-testing device that can be used at home to perform cellular health screening tests.

The urine sample segment also accounted for a significant market share as it is a quicker, patient-friendly, and less invasive sample to collect. Genova Diagnostics offers Oxidative Stress Analysis 2.0 that evaluates oxidative stress status in the body. This test uses urine as a sample to detect two key biomarkers - lipid peroxides and 8-OHdG - that cause oxidative stress damage. Thus, the increasing prevalence of oxidative stress is also expected to boost segment growth during the forecast period.

Collection Sites Insights

The hospitals segment dominated the market with a share of 39.33% in 2020. Hospitals facilitate primary treatment and diagnostics for a majority of the population. Diagnostic tests related to cellular health screening for most of the in-patient population are typically conducted in hospitals and clinics as physicians recommend reliable diagnostic processes for testing as well as sample collection. Thus, the hospitals segment is expected to have significant growth over the coming years. Moreover, the availability of trained professionals facilitating easy and safe sample collection and testing processes will also support the segment growth.

Global cellular health screening market share, by collection sites, 2020 (%)

Home collection sites is projected to register the fastest CAGR from 2021 to 2028 owing to the increasing adoption of self-sampling in key markets as it is user-friendly and does not require specialized lab infrastructure and professional training. The global COVID-19 pandemic has further supported the home collection segment due to lockdowns and movement restrictions in the major economies.

Regional Insights

North America accounted for the largest market share of 47.46% in 2020 and is expected to maintain its leading position during the forecast period. An increase in the importance of Healthy Life Expectancy (HALE), government focus on preventive healthcare, and a rise in the burden of chronic diseases are some of the key factors expected to boost the market growth in the region. The U.S. accounted for the maximum share in the regional market. Key factors contributing to its dominance include the presence of major market players, easy availability of telomere & oxidative stress tests, high adoption of test-from-home, and increasing awareness about rare diseases.

Asia Pacific is estimated to be the fastest-growing regional market owing to the presence of the target population and improving healthcare infrastructure in developing economies. Other factors driving the regional market include increasing adoption and awareness about telomere performance programs by developing countries. Furthermore, the growing awareness about HALE, increasing government attention on preventive healthcare, growing geriatric population, and rising burden of chronic disorders are estimated to support the regional growth.

Key Companies & Market Share Insights

The market includes a large number of well-established and emerging players. These players are adopting various strategies, such as the launch of new products, collaborations, geographical expansion, and partnerships, to strengthen their position in the market. For instance, in October 2016, Telomere Diagnostics launched TeloYears, which helps in monitoring the vitality of cells based on telomere length. Some prominent players in the global cellular health screening market include:

  • Telomere Diagnostics

  • SpectraCell Laboratories

  • Life Length

  • Repeat Diagnostics, Inc.

  • Cell Science Systems Corp.

  • Quest Diagnostics

  • LabCorp Holdings

  • OPKO

  • Genova Diagnostics

  • Immunodiagnostik AG

  • DNA Labs

Cellular Health Screening Market Report Scope

Report Attribute

Details

Market size value in 2021

USD 2.26 billion

Revenue forecast in 2028

USD 3.47 billion

Growth rate

CAGR of 6.3% from 2021 to 2028

Base year for estimation

2020

Historical data

2016 - 2020

Forecast period

2021 - 2028

Quantitative units

Revenue in USD million/billion and CAGR from 2021 to 2028

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Test type, sample test, collection sites, and region

Regional scope

North America; Europe; Asia Pacific; Latin America; MEA

Country scope

U.S.; Canada; U.K.; Germany; Spain; France; Italy; Russia; China; India; Japan; South Korea; Singapore; Australia; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE

Key companies profiled

Telomere Diagnostics; SpectraCell Laboratories; Life Length; Repeat Diagnostics, Inc.; Cell Science Systems Corp.; Quest Diagnostics; LabCorp Holdings; OPKO; Genova Diagnostics; Immunodiagnostik AG; DNA Labs

Customization scope

Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options


Segments Covered in the Report

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2028. For the purpose of this study, Grand View Research has segmented the global cellular health screening market report on the basis of test type, sample test, collection sites, and region:

  • Test Type Outlook (Revenue, USD Million, 2016 - 2028)

    • Single Test Panels

      • Telomere Tests

      • Oxidative Stress Tests

      • Inflammation Tests

      • Heavy Metals Tests

    • Multi-test Panels

  • Sample Test Outlook (Revenue, USD Million, 2016 - 2028)

    • Blood

    • Saliva

    • Serum

    • Urine

  • Collection Sites Outlook (Revenue, USD Million, 2016 - 2028)

    • Home

    • Office

    • Hospital

    • Diagnostic Labs

  • Regional Outlook (Revenue, USD Million, 2016 - 2028)

    • North America

      • U.S.

      • Canada

    • Europe

      • U.K.

      • Germany

      • Spain

      • France

      • Italy

      • Russia

    • Asia Pacific

      • Japan

      • China

      • India

      • South Korea

      • Singapore

      • Australia

    • Latin America

      • Brazil

      • Mexico

      • Argentina

    • MEA

      • South Africa

      • Saudi Arabia

      • UAE

Frequently Asked Questions About This Report

gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself...

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.